OCUP Ocuphire Pharma, Inc.

Ocuphire Pharma is a clinical-stage ophthalmic biopharmaceutical company focused on developing and commercializing therapies for the treatment of several eye disorders.

As of 07/01/2022     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  11/10/2005
Outstanding shares:  19,364,367
Average volume:  113,614
Market cap:   $37,179,585
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Valuation   (See tab for details)
PE ratio:   -2.07
PB ratio:   2.10
PS ratio:   0.00
Return on equity:   -140.54%
Net income %:   -4,121,222.41%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy